Loading stock data…
Loading stock data…
US$0.94
Get one email when CGTX crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.96%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
37.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.07
Bearish momentumMACD below its signal line (-0.05).
50-day average
1.20
Price belowShort-term trend reference.
200-day average
1.31
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Cognition Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. Its lead candidate, zervimesine (also known as CT1812), is an investigational oral small molecule designed to penetrate the blood-brain and blood-retina barriers, selectively bind to the sigma-2 receptor complex, and restore normal neuronal functions such as autophag…
www.cogrx.com2 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-07-01)
2 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-06-01)
2 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-05-01)
2 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | -0.07 | -0.05 | ✓ Beat |
| 2026-03-26 | -0.08 | -0.02 | ✓ Beat |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-11-18 | 0.25 | 0.33 | ✓ Beat |
| 2025-11-06 | -0.09 | -0.06 | ✓ Beat |
| 2025-09-29 | -0.18 | -0.11 | ✓ Beat |
| 2025-08-07 | -0.1 | -0.11 | ✗ Miss |
| 2025-05-07 | -0.11 | -0.14 | ✗ Miss |
Companies in the same industry, via Finnhub